Jump to content

Recommended Posts

Hi, SMAs,

Here is the weekly clip report:
 
Healio
“Targeted Radiation Reduces Mortality for Early-Stage Lung Cancer”
https://www.healio.com/hematology-oncology/lung-cancer/news/in-the-journals/{ea2da7d0-cbee-4aba-bba7-5028dde05d69}/targeted-radiation-reduces-mortality-for-early-stage-lung-cancer

OncLive
“ALK Inhibitors Continue to Reshape Treatment in NSCLC”
http://www.onclive.com/web-exclusives/alk-inhibitors-continue-to-reshape-treatment-in-nsclc

U.S. News & World Report
“Are More People Dying of Cancer?”
https://health.usnews.com/health-care/patient-advice/articles/2018-02-20/are-more-people-dying-of-cancer

Women’s Health
“’How I Told My Siblings I Had Lung Cancer’”
https://www.womenshealthmag.com/health/a18377542/lung-cancer-diagnosis/

OncLive
“Clinical Trials Highlight Biomarker Progress in Lung Cancer”
http://www.onclive.com/web-exclusives/clinical-trials-highlight-biomarker-progress-in-lung-cancer

Clinical Oncology
“Imfinzi Granted New Indication to Reduce Risk for NSCLC Progression”
http://www.clinicaloncology.com/FDA-Watch/Article/02-18/Imfinzi-Granted-New-Indication-to-Reduce-Risk-for-NSCLC-Progression/47007

OncLive
“Larotrectinib Update Shows Durable Responses in TRK-Positive Cancers”
http://www.onclive.com/web-exclusives/larotrectinib-update-shows-durable-responses-in-trkpositive-cancers

Cancer Therapy Advisor
“Phase 2 Trial of AZD1775 for Squamous Cell Lung Cancer”
https://www.cancertherapyadvisor.com/lung-cancer/azd1775-squamous-cell-lung-cancer-phase-2-trial/article/746115/

BBC News
“Mini-Tumors’ Created to Battle Cancer”
http://www.bbc.com/news/health-43154878

Medical Xpress
“An Under-the-Radar Immune Cell Shows Potential in Fight Against Cancer”
https://medicalxpress.com/news/2018-02-under-the-radar-immune-cell-potential-cancer.html

GenomeWeb
“New Extracellular Particle Could Prove Useful for Cancer Diagnosis, Monitoring”
https://www.genomeweb.com/proteomics-protein-research/new-extracellular-particle-could-prove-useful-cancer-diagnosis
 

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.